Ictalurid herpesvirus 1 (IcHV-1), also known as Channel Catfish Virus (CCV), is a member of the Alloherpesviridae family. ORF21 is one of 58 open reading frames (ORFs) identified in the IcHV-1 genome, spanning approximately 1,347 base pairs. While its exact function remains undefined, bioinformatic analyses suggest it encodes a putative 448-amino-acid protein with homology to tegument proteins in other herpesviruses. Recombinant ORF21 is produced via heterologous expression systems to enable structural and functional studies.
Recombinant ORF21 has been successfully expressed in Escherichia coli and baculovirus-insect cell systems. Key protocols and yields include:
| Expression System | Yield | Purification Method | Purity |
|---|---|---|---|
| E. coli BL21(DE3) | 12 mg/L | Ni-NTA affinity chromatography | >90% |
| Sf9 insect cells | 8 mg/L | Size-exclusion chromatography | >95% |
Western blot analyses confirm reactivity with anti-HisTag antibodies, validating successful expression.
ORF21 is a focus of aquaculture vaccine development due to its immunogenicity in channel catfish. Challenges include:
Low solubility in E. coli systems, necessitating fusion tags or refolding protocols.
Antigenic variability, complicating vaccine design.
Priority research areas include:
Crystal structure determination to map interaction sites.
Knockout studies to assess impact on viral replication.
Comparative analyses with ORF21 homologs in related herpesviruses.
ORF21 is an uncharacterized protein encoded by Ictalurid herpesvirus 1 (strain Auburn), also known as Channel catfish virus. Taxonomically, IcHV-1 belongs to the realm Duplodnaviria, kingdom Heunggongvirae, phylum Peploviricota, class Herviviricetes, order Herpesvirales, family Alloherpesviridae, and genus Ictavirus . The virus causes significant economic losses in channel catfish and blue catfish farming operations, with disease outbreaks occurring particularly during warm summer months and in crowded aquaculture conditions .
The recombinant Ictalurid herpesvirus 1 ORF21 protein is expressed in E. coli expression systems with a purity of >85% as determined by SDS-PAGE . Unlike the native viral protein, which exists within the context of the virion structure, the recombinant form contains the full-length protein (expression region 1-296) and may include a tag determined during the manufacturing process . The recombinant protein lacks post-translational modifications that might occur in the natural fish cell environment, which could affect its functional properties when used in experimental setups.
For optimal expression and purification of recombinant ORF21:
Expression System: E. coli is the preferred system for ORF21 expression due to high yield and cost-effectiveness .
Purification Protocol:
Reconstitution:
Storage Conditions:
When designing experiments to characterize ORF21 function in viral replication:
Knockdown Approaches: Design short hairpin RNAs (shRNAs) targeting ORF21, similar to those used for ORF59 studies . This allows assessment of the effect of ORF21 silencing on virus replication.
Protein Blocking Assay: Develop blocking assays using purified recombinant ORF21 to determine if it interferes with virus-host interactions .
Subcellular Localization Studies:
Viral DNA Synthesis Inhibition Assessment: Measure viral DNA replication in the presence or absence of functional ORF21 .
Time-course Analysis: Monitor ORF21 expression during different stages of viral infection to determine if it's an early or late gene product .
To identify interaction partners of ORF21, researchers should employ:
Co-immunoprecipitation (Co-IP):
Yeast Two-Hybrid Screening:
Use ORF21 as bait to screen fish cDNA libraries
Validate positive interactions with secondary assays
Protein Microarrays:
Probe arrays containing host cell proteins with labeled recombinant ORF21
Identify binding events through detection systems
Proximity-based Labeling Techniques:
Fuse ORF21 with BioID or APEX2
Identify proximal proteins through biotinylation and streptavidin pull-down followed by mass spectrometry
Cross-linking Mass Spectrometry:
Stabilize transient interactions through chemical cross-linking
Identify interaction sites at the amino acid resolution level
Comparative analysis reveals several distinctions between ORF21 and other IcHV-1 proteins:
| Protein | Size (aa) | Major Functions | Cellular Localization | Expression Timing |
|---|---|---|---|---|
| ORF21 | 296 | Uncharacterized | Unknown | Unknown |
| ORF45 | 240 | Uncharacterized | Unknown | Unknown |
| ORF59 | - | Envelope glycoprotein, viral entry | Membrane/envelope | Late-stage infection |
| ORF61 | 319 | Uncharacterized | Unknown | Unknown |
Unlike ORF59, which is confirmed as a viral envelope glycoprotein essential for virus entry into host cells , the functional role of ORF21 remains largely uncharacterized. ORF21 lacks the hydrophobic domains seen in ORF59 that span the viral membrane . While ORF59 contains N-linked glycosylation sites positioned on the external surface of the virion , such features have not been identified in ORF21.
While direct homologs of ORF21 in other herpesviruses are not well established, comparative genomic approaches reveal:
Structural Features: ORF21 contains serine-glutamic acid (SE) repeat motifs similar to those found in certain herpesvirus regulatory proteins .
Functional Parallels: Other alloherpesviruses encode proteins with similar sequence regions, suggesting potential conserved functions. For example, cyprinid herpesviruses and anguillid herpesvirus 1 (AngHV-1) contain ORFs with regional homology .
Evolutionary Relationship: Analysis using standard bioinformatic tools for assessing codon preference, third-position codon G+C bias, and amino acid sequence conservation suggests ORF21 may share functional roles with proteins in related fish herpesviruses .
KSHV Comparison: Unlike KSHV ORF10, which interacts with Rae1-Nup98 complex to block cellular mRNA export selectively , no similar function has been established for IcHV-1 ORF21.
While direct evidence for ORF21's role in immune evasion is limited, several hypotheses can be tested:
Potential Interference with Antiviral Signaling: ORF21 may function similarly to other herpesvirus proteins (like KSHV ORF45) that inhibit interferon responses . The protein's unique sequence suggests it could potentially interact with fish-specific immune factors.
Regulation of Host Gene Expression: The SE-repeat region of ORF21 resembles domains involved in protein-protein interactions and could potentially modulate host transcription or translation machinery .
Experimental Approaches:
Compare fish immune responses between wild-type virus and ORF21-knockout viruses
Examine changes in host gene expression profiles in cells expressing ORF21
Assess ORF21 interaction with known components of fish innate immunity
Parallel with Other Herpesviruses: Kaposi's sarcoma-associated herpesvirus (KSHV) contains viral proteins that selectively inhibit cellular mRNA export to control cellular gene expression . ORF21 could play a similar role in IcHV-1 infection.
Development of ORF21-based diagnostics for IcHV-1 would involve:
Recombinant Antigen Production:
Antibody Development:
ELISA-based Detection Systems:
Develop sandwich ELISA using anti-ORF21 antibodies
Validate specificity and sensitivity using known positive and negative samples
PCR-based Methods:
Design primers targeting the ORF21 gene region
Develop quantitative PCR assays for viral load determination
Field Validation: Test diagnostic tools in aquaculture settings to establish sensitivity, specificity, and predictive values.
Computational approaches for predicting ORF21 functions include:
Structural Prediction and Analysis:
Use AlphaFold or similar tools to predict 3D structure
Identify structural motifs that might suggest function
Perform molecular dynamics simulations to understand conformational dynamics
Sequence-Based Functional Prediction:
Identify conserved domains through comparison with protein family databases
Analyze the SE-repeat region for potential binding sites
Examine post-translational modification sites through predictive algorithms
Comparative Genomics:
Network-Based Predictions:
Predict protein-protein interactions based on sequence characteristics
Integrate with known viral-host protein interaction networks
Machine Learning Approaches:
Train models using known herpesvirus protein functions
Apply transfer learning techniques to predict ORF21 functions
The potential role of ORF21 in viral latency and reactivation can be explored through:
Gene Expression Analysis: Monitor ORF21 expression levels during latent infection and viral reactivation using RT-PCR and Western blotting techniques similar to those used for other IcHV-1 genes .
Comparison with Known Regulators: Drawing parallels with better-characterized herpesviruses like KSHV, where proteins such as RTA and RAP are key regulators of the lytic switch .
Functional Studies:
Develop ORF21 overexpression systems to assess effects on viral gene expression
Create ORF21 knockout or mutant viruses to observe impacts on establishment of latency and reactivation efficiency
Employ techniques similar to those used for KSHV ORF10 studies, which demonstrated roles in viral late gene expression
Hypothesis: The serine-glutamic acid (SE) repeats in ORF21's C-terminal region could potentially interact with host factors involved in transcriptional regulation or chromatin modification that influence latency maintenance.
Advanced imaging approaches for studying ORF21 include:
Live-Cell Imaging:
Super-Resolution Microscopy:
Apply techniques like STORM or PALM to visualize ORF21 distribution at nanoscale resolution
Examine co-localization with cellular compartments and other viral proteins
Correlative Light and Electron Microscopy (CLEM):
Combine fluorescence microscopy with electron microscopy to correlate ORF21 localization with ultrastructural features
Identify precise subcellular locations during different infection stages
Fluorescence Recovery After Photobleaching (FRAP):
Assess mobility and binding dynamics of ORF21 in different cellular compartments
Compare with known viral tegument or envelope proteins
Proximity Ligation Assay (PLA):
Detect in situ protein-protein interactions between ORF21 and candidate cellular or viral partners
Visualize interaction networks during infection progression
Development of ORF21-targeted antivirals would involve:
Structure-Based Drug Design:
Use structural data from recombinant ORF21 to identify potential binding pockets
Perform in silico screening of compound libraries against identified targets
Design peptide inhibitors based on interaction interfaces
RNA Interference Approaches:
CRISPR/Cas-Based Strategies:
Design guide RNAs targeting the ORF21 gene region
Develop delivery methods suitable for fish cells
Protein-Protein Interaction Inhibitors:
Efficacy Testing:
Common challenges with recombinant ORF21 include:
Protein Solubility Issues:
Challenge: Recombinant ORF21 may form inclusion bodies in E. coli
Solution: Optimize expression conditions (temperature, IPTG concentration)
Alternative: Express as fusion protein with solubility tags like MBP or SUMO
Protein Stability Concerns:
Functional Activity Assessment:
Antibody Specificity:
To optimize experimental protocols for ORF21-host cell interaction studies:
Cell System Selection:
Transfection Protocol Optimization:
Protein-Protein Interaction Methods:
Adapt co-immunoprecipitation protocols for fish cell systems
Consider temperature adjustments for all binding assays
Implement proper controls to account for non-specific binding
Viral Infection Models:
Data Analysis and Integration:
Combine results from multiple experimental approaches
Use statistical methods appropriate for the experimental design
Compare findings with known information about other IcHV-1 proteins